clomiphene effects on idiopathic premature ejaculation

results within the 10-month study course, 126 patients (70.8%) completed this study. after intervention and comparison of the results between the two groups, ielt, sexual indexes, and qol improved in the study group, but significant differences were observed only in the ielt and qol findings. objectives our objective in this study was to evaluate the efficacy and safety of clomiphene as a selective estrogen receptor modulator on the treatment of idiopathic pe. patients and methods in a randomized clinical trial, 178 married men with idiopathic pe defined according to the diagnostic and statistical manual of mental disorders third revised version (dsm-iii-r) who referred to urology clinics over a 10-month period in 2012 were randomized into two groups, namely the study (clomiphene) and control (placebo) groups. they completed self-administered questionnaires that included intravaginal ejaculatory latency time (ielt), erectile dysfunction indexes, quality of life (qol), sociodemographic characteristics, lifestyle, and medical illness. after 6 months of intervention, all data were compared with the baseline data and between the groups. background premature ejaculation (pe) is the inability to delay ejaculation, occurring sooner than they or their partner would like during sexual activities. pe is a challenging problem that can affect sexual enjoyment and may harm relationships of couples and affect their quality of life. in idiopathic pe, several helpful techniques and medicines are recommended, but none of them has yielded satisfactory results. conclusions clomiphene seems to be useful in the pharmacological treatment of pe compared to the placebo.